Skip to main content

News

You are here

UM Ventures News

Biogen Acquires Remedy Pharmaceuticals’ CIRARA™ for Large Hemispheric Stroke

Biogen (NASDAQ: BIIB) announced today that it has completed an asset purchase of Remedy Pharmaceuticals’ Phase 3 candidate, CIRARA™ (intravenous glyburide).

8 ways the National Science Foundation supports our troops

Read a story on the numerous way the National Science Foundation (NSF) supports our troops.

USM Launches $25 Million Maryland Momentum Fund to Back Start-Up Companies Formed from Campus Research

The Maryland Momentum Fund will concentrate on filling gaps in the funding pipeline to push USM's most innovative ideas into the marketplace.

USM Announces New Venture Fund

Pages